Management has stated they are done with covid studies. The only way Lenz gets approved is if the FDA approves it with studies that have been done already and this led to a decline of the drug by the FDA or another company or group runs a trial with Lenz. I don't see either of these scenarios happening.
Market Data 
Markets 
AI
